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The application of metabolomics, the global analysis of metabolite levels, to the study of protozoan parasites
has become an important tool for understanding the host-parasite relationship and holds promise for the
development of direly needed therapeutics and improved diagnostics. Research advances over the past
decade have opened the door for a systems biology approach to protozoan parasites with metabolomics,
providing a crucial readout of metabolic activity. In this review, we highlight recent metabolomic approaches
to protozoan parasites, including metabolite profiling, integration with genomics, transcription, and proteo-
mic analysis, and the use of metabolic fingerprints for the diagnosis of parasitic infections.Introduction
Enzymes are central to every aspect of biology, and metabolite
levels (as substrates, products, and cofactors) are the crucial
readout of the combined enzyme and transporter activity within
cells. Technological advances during the past decade now allow
for the rapid and accurate measurement of the abundance levels
of hundreds to thousands of metabolites simultaneously from
complex mixtures. These techniques, collectively referred to as
metabolomics, fill a crucial gap alongside data from other global
approaches characterizing genes, transcripts, and proteins in
the push toward a systems-level characterization of cells. Me-
tabolomic analysis has been widely applied to study the systems
biology of numerous model organisms across the tree of life,
including Archeae (Trauger et al., 2008), Eubacteria, (Rabinowitz,
2007), fungi, (Brauer et al., 2006), plants (Cho et al., 2008; Lisec
et al., 2008), animals (Pedersen et al., 2008; Sun et al., 2007), and
human cell tissue culture (Khoo and Al-Rubeai, 2007). Applica-
tion of metabolomics to the study of protozoan parasites, while
still in its infancy, is rapidly emerging as a fertile approach to
better understand the host-parasite interaction.
Protozoan parasites cause serious infections in humans and
animals, including life-threatening diseases such as malaria
(Plasmodium spp.), African sleeping sickness (Trypanosoma
brucei), Chagas disease (Trypanosoma cruzi), and leishmaniasis
(Leishmania spp.). Though these diseases affect few in the devel-
oped world, they continue to threaten the health and livelihood
of a large portion of humanity. To make matters worse, once
efficacious antimalarial drugs, such as the antifolates and 4-
aminoquinolines, have been rendered useless due to wide-
spread parasite resistance (Guerin et al., 2009).
From a systems biology perspective, studying parasitic
disease is particularly enticing, as it inherently involves the
complex interplay of two interconnected biological systems
with a net flow of energy and nutrients between the host and
the parasite. In the process of adapting to their host niche, these
organisms have evolved reduced metabolic capacity, often
drastically so, while expanding mechanisms for avoiding host
defense and for utilizing metabolites from their hosts. Some,90 Cell Host & Microbe 7, February 18, 2010 ª2010 Elsevier Inc.like the African trypanosome, are so adept at avoiding the host
defense mechanisms that they grow freely in the blood stream,
where they are bathed in nutrients. Others, such as the malaria
parasite, have adapted to life within host cells, which offers
certain protections but can place additional barriers to nutrient
acquisition. Many parasites must also infect multiple host
species in order to complete their lifecycle, which can require a
drastic remodeling of parasite metabolism to adapt to an entirely
different metabolic milieu, as in the mammal/arthropod transi-
tions of vector-borne parasites (Aly et al., 2009).
The current paucity of effective preventative or therapeutic
options is another strong motivation for the study of parasite
metabolism. No effective vaccine exists for the prevention of
protozoan parasitic disease in humans, and the number of effec-
tive and affordable drugs, small to begin with, is progressively
shrinking with rising incidence of resistance, making the devel-
opment of novel antiparasitic drugs imperative. Most drugs
against infectious disease exploit differences in metabolism by
targeting pathogen enzymes that are absent or highly divergent
from those of the host (Agu¨ero et al., 2008). This strategy has
been highly successful for evolutionarily distant bacterial patho-
gens, but protozoan parasites, as fellow eukaryotes, present
fewer divergent drug targets due to a shared eukaryotic ancestry
and their reduced metabolic capacity. Understanding parasite
metabolic networks, including the role of novel organelles such
as the apicomplexan apicoplast (the nonphotosynthetic remnant
of an algal symbiont) (Seeber et al., 2008) or the mitosomes/hy-
drogenosomes of low branching protozoa (Hackstein et al.,
2006), will be crucial for developing effective new drugs.
The current state of research on protozoan parasites is primed
for systems biology approaches, including global metabolite
analysis. With few exceptions, one or more stages of the impor-
tant protozoan pathogens of humans can be grown in culture to
densities that allow isolation of significant amounts of DNA, RNA,
proteins, and metabolites. Annotated draft sequences exist of
genomes from all major groups of protozoan pathogens that
infect humans (many accessible via http://www.eupathdb.org).
The available genomes and expressed sequence tags have
Figure 1. Commonly Used Methodologies in Metabolomics
The diagram above outlines the major steps of metabolomic experiments, along with some commonly used options available for each step. Prior to sample pro-
cessing, biological materials of interest may be isotopically enriched to follow the metabolism of labeled compounds over time. Some technologies, such as
nuclear magnetic resonance (NMR) spectroscopy, allow for the monitoring of metabolites within live organisms or assaying whole lysate directly, but often,
sample complexity is reduced by either limiting the material sampled to specific biofluids (e.g., urine or plasma) or performing solvent extractions (e.g., meth-
anol/water, methanol/chloroform, or perchlorate). Furthermore, mass spectrometry (MS) and spectroscopic (infrared [IR] or ultraviolet [UV]) approaches often
utilize chromatography (gas [GC], liquid [LC], or high-performance liquid [HPLC]) or capillary electrophoresis (CE) to limit the sample complexity entering the
detector at any one time and to determine a characteristic retention time. Mass spectrometry utilizes the retention time for a given metabolite, as well as the
mass/charge ratio (MS), often in conjunction with the mass/charge ratio of fragmentation daughter ions in tandem MS (MS/MS), for identification. NMR exploits
structurally dependent changes in the magnetic resonance of suitable nuclei (e.g., 1H, 13C, or 31P) for metabolite identification. Light spectroscopic approaches
do not perform aswell for the individual identification of metabolites but represent amore cost-effective approach to determining changes in the overall metabolic
profile or fingerprint of a sample. Both NMR andMS approaches offer the possibility for the detection of dozens to hundreds of individual metabolites, but recent
advances also permit more accurate measurements of metabolite concentrations, which are critical for determiningmetabolite fluxes within ametabolic network.
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for the design of DNA microarrays that have already been used
extensively for transcriptome analysis of numerous parasites,
including Plasmodium spp., T. gondii, and the kinetoplastids.
Integrating metabolomics with the analysis of the genomic,
transcriptomic, and proteomic data already in place opens the
door for systematic study of the host-parasite interaction that
will lead to a deeper biological understanding and is likely to
unveil additional targets for prevention and therapy. In this
review, we aim to outline the current status of using metabolo-
mics in the study of protozoan parasites and highlight numerous
promising applications.
Definitions and Methodology
Broadly defined, the ‘‘metabolome’’ is the collection of all small
molecules (<1 kDa) of a given system, and ‘‘metabolomics’’ is
the characterization of this set by one or more techniques. The
more narrowly defined term ‘‘metabonomics’’ refers to the quan-
titative measurement of metabolic responses over time within
a system in response to an event (infection, drug treatment, star-
vation, etc.) (Holmes et al., 2008). In the case of a host-parasite
system, metabolomics often involves the characterization and
interplay of each organism’s metabolome or a characterization
of the host cell’s metabolome in the absence or presence of
the parasite, known as the cometabolome (Holmes et al., 2008).
Historically, enzyme-based assays and tracing of radiolabeled
nutrients were the major tools for assaying parasite metabolism
(Sherman, 1998). Today, nuclear magnetic resonance (NMR)spectroscopy and separation-linked single (MS) or tandem
(MS/MS) mass spectrometry are the major tools in use for
metabolomics. Their use in metabolomics has been expertly re-
viewed elsewhere (Bollard et al., 2005; Lenz and Wilson, 2007;
Want et al., 2007). Two recent reviews by Besteiro et al. and
Scheltma et al. also provide a helpful overview of available
metabolomic approaches in parasitology as applied to the anal-
ysis of phospholipid biosynthesis in Plasmodium spp. (Besteiro
et al., 2010) and Leishmania (Scheltema et al., 2010), respec-
tively. We provide a cursory overview of various methodological
options in Figure 1, but a more detailed description and compar-
ison of these technologies is outside its scope.
Laying the Groundwork: Profiling ParasiteMetabolomes
A number of pioneering studies published in the 1980s first
applied NMR spectroscopy to parasite metabolism (expertly re-
viewed by S.N. Thompson [Thompson, 1991]). Many of these
early studies focus on the profiling of major parasite metabolites.
To avoid significant overlap with this comprehensive review, our
review will focus only on subsequently published work.
Since 1990, 31P-NMR has continued to be used for profiling
various aspects of parasite phosphate metabolism in Plasmo-
dium spp., Toxoplasma gondii, and Cryptosporidium parvum
(Moreno et al., 2001), as well as in the kinetoplastids (Mendoza
et al., 2002). Similarly, the use of 13C-NMR for metabolite
mapping has also continued, including the characterization of
abundant metabolites in Entamoeba histolytica- (Bakker-Grun-
wald et al., 1995) and P. falciparum-infected erythrocytes (LianCell Host & Microbe 7, February 18, 2010 ª2010 Elsevier Inc. 91
Cell Host & Microbe
Reviewet al., 2009), measuring glucose flux in P. falciparum- and P. yoe-
lii-infected erythrocytes (Mehta et al., 2006), and measuring the
suppression of glycolytic activity in uninfected erythrocytes by
malaria-conditioned medium (Mehta et al., 2006).
With increasing magnet strength and improved signal filtering,
the use of 1H-NMR for metabolite mapping has steadily grown
and yielded several studies mapping the metabolome of kineto-
plastid parasites, including L. donovani (Gupta et al., 1999) and
T. cruzi (Penin et al., 1998), as well as the lipidome of L. donovani
(Adosraku et al., 1993). A recent metabolic analysis of P. falcipa-
rum trophozoite extracts compared several extraction condi-
tions and identified more than 50 metabolites with measured
concentrations in the high nM/low mM range for 40 separate
metabolites (Teng et al., 2009). A surprising finding of this study
included the accumulation of HEPES within the parasite, a
buffering agent used in culture medium, further highlighting the
considerable differences between in vitro and in vivo growth
conditions (reviewed in LeRoux et al., 2009). In a complementary
study using an LC-MS/MS approach, Olszewski et al. sampled
synchronous P. falciparum blood-stage cultures at 8 hr intervals
and assayed 89 knownmetabolites across the 48 hr intraerythro-
cytic cycle (Olszewski et al., 2009).
Kamleh and colleagues compared the metabolome of T. bru-
cei procyclic forms grown on glucose, the preferred carbon
source, or proline, which is abundantly available in the Tsetse fly
vector. Using hydrophilic interaction chromatography (HILIC)
and electrospray ionization (ESI) mass spectrometry, more
than 1000 distinct peaks were resolved, including many phos-
pholipids and lipophilic amino acids, which can be difficult to
resolve using standard reverse-phase HPLC. Numerous metab-
olites changed significantly in abundance following a switch in
carbon source from glucose to proline, including several gluta-
mine derivatives and phospholipids (Kamleh et al., 2008). Finally,
an earlier study determined the uptake and catalysis of poly-
amines and thiols by T. cruzi trypomastigotes and amastigotes
by HPLC/MALDI-TOF MS (Ariyanayagam et al., 2003).
Toward Parasite Systems Biology: Integrating Global
Approaches
Whereas small molecule profiling provides an important baseline
for the metabolic characterization of parasites, studying their
metabolic response (and underlying regulation) due to environ-
mental or genetic changes has the potential to yield greater
insight into parasite biology by investigating how the interplay
of genetics and environment affects changes in the metabolome
and how changing metabolites feed back into the regulation of
gene expression and enzymatic activity.
Inferring Metabolic Networks: Pitfalls and Promises
The sequencing of parasite genomes has yielded unprece-
dented insights into how parasites have adapted to their various
niches and have become increasingly dependent on their hosts
by sacrificing the ability to synthesize nutrients de novo for
less-energy-intensive scavenging mechanisms. Identification
of conserved metabolic enzyme pathways (Pinney et al., 2005)
and nutrient transporters (Ginsburg and Stein, 2005; Martin
et al., 2005) by comparative genomics has allowed the construc-
tion of metabolic networks for these organisms in silico (Chavali
et al., 2008; Ma and Zeng, 2003). These networks have been
a powerful tool in guiding parasite research by laying out para-92 Cell Host & Microbe 7, February 18, 2010 ª2010 Elsevier Inc.sites’ anabolic and catabolic potential (Pinney et al., 2005), high-
lighting potential drug targets (Cornish-Bowden and Ca´rdenas,
2003; Pinney et al., 2007), and attempting to identify metabolic
gaps and novel pathways (Huthmacher et al., 2008; Zamboni
and Sauer, 2009).
A variety of interfaces and databases are available to browse
the annotated genomes of protozoan parasites, with http://
www.eupathdb.org being the most comprehensive. The annota-
tion depth and quality of parasite genomes varies considerably
between species according to funding and human capital in-
vested to date. Protein coding genes are generally automatically
annotated by a variety of homology methods (Interproscan,
OrthoMCL-DB) and assigned Gene Ontology function terms
and Enzyme Commission numbers when possible. A number
of automated and hand annotated approaches have been
used to build metabolic networks of protozoan parasites from
functionally annotated genes, including the metaTiger KEGG
interface, the ApiCyc and LeishCyc databases, and the Malaria
Parasite Metabolic Pathways (MPMP) database. In a recent
review, Hagai Ginsburg outlines advantages and shortcomings
of these approaches for building metabolic networks of the ma-
laria parasite—lessons that are likely to apply generally to
attempts of building metabolic pathways of other protozoa
(Ginsburg, 2009). An inherent shortcoming of homology-based
approaches for predicting metabolic networks is that they
cannot predict the function of novel or highly divergent metabolic
genes. Such ‘‘hypothetical’’ genes of unknown function repre-
sent a sizable fraction of predicted genes in the available parasite
genomes (Carlton et al., 2008). Depending on their activity,
unidentified metabolic genes among them could alter the struc-
ture of metabolic networks considerably.
Finding Missing and Essential Links: Using
Metabolomics to Improve Metabolic Networks
In silico metabolomic networks are particularly valuable for iden-
tifying metabolic gaps, ‘‘missing’’ enzymes based on otherwise
complete pathways or orphan biochemical activities, and for
highlighting differences in host and parasite metabolism that
may be exploited for drug therapy. Apart from enzymatic
evidence, various sources of experimental data have been
used to improve the accuracy of metabolic networks based on
genomic sequence, including phylogenetic conservation of
pathways (Chen and Vitkup, 2006), patterns of coexpression at
the transcript (Brauer et al., 2005) or protein level (May et al.,
2008), and, increasingly, metabolite presence and abundance
(Brauer et al., 2006; Breitling et al., 2008; May et al., 2008).
Recently, Mohanty et al. used a homology-based search for
missing enzymes to assign putative function to several ‘‘hypo-
thetical’’ genes and fill 14 of their 69 predicted metabolic gaps
in P. falciparum (Mohanty and Srinivasan, 2009). Comprehensive
profiling of parasite metabolomes is certain to reveal additional
gaps through the identification of ‘‘orphan’’ metabolites or activ-
ities. Ultimately, the use of metabolomics for the identification
of previously uncharacterized metabolites will also set off the
search for the enzymes involved in their synthesis (Kalisiak
et al., 2009).
Recent studies have used metabolic network analysis to iden-
tify essential activities in protozoan parasites that may be prom-
ising targets for drug design. In an excellent example of this
approach, Chavali et al. mapped a metabolic network of
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tions, 1101 metabolites, and 8 subcellular localizations across
both the amastigote and trypomastigote life stages. Using this
network, the authors were able to predict minimal parasite nutri-
tional requirements, as well as metabolic reactions that are
essential to parasite survival for both single- and double-
knockout mutations (Chavali et al., 2008). In a similar approach,
Roberts et al. used a combination of genomic and proteomic
data to generate a compartmental model of T. cruzi epimastigote
metabolism covering 215 genes, 162 reactions, and 158 metab-
olites. In addition to using this approach for predicting essential
enzymatic activities, they identified several enzymes that are
critical for epimastigote survival that were previously thought
to be nonessential, and also found reactions that were previously
thought essential, whichwere dispensable. Taking their research
a step further, these predictions were validated using RNA inter-
ference (Roberts et al., 2009). Using an in silico approach, Yeh
et al. (Yeh et al., 2004) and Fatumo et al. (Fatumo et al., 2009)
used metabolic network analysis to identify essential enzyme
activities in Plasmodium falciparum. Analyses such as these are
currently being combined with other considerations to prioritize
parasite drug targets by the WHO in pathogens causing
neglected diseases (Agu¨ero et al., 2008).
Many properties of metabolic networks cannot be fully deter-
mined based on interconnectivity and coexpression alone but
depend critically on the reaction rates of each step (Sauer,
2006). Metabolite flux through the network can be probed by
feeding isotopically labeled nutrients and following label incor-
poration into downstream metabolites by successive metabolo-
mic analyses (Zamboni et al., 2009). Isotopic labeling can reveal
nonintuitive network behavior and network redundancy (Blank
et al., 2005), highlighting potential drug targets (Munger et al.,
2006) and mechanisms of action (Kwon et al., 2008) that are not
apparent based on interconnectivity alone. With the exception of
work on the E. histolytica glycolysis pathway (Moreno-Sa´nchez
et al., 2008), very little work has been done on metabolic flux
analysis in protozoan parasites. The application to host-parasite
systems is likely to be an important tool for rational drug design
of novel antiparasitic compounds and understanding the mech-
anisms of action of existing drugs, such as artemisinin, which
remain contentious (Eastman and Fidock, 2009).
These studies illustrate how interpreting parasite metabolism
in light of the genome alone can be misleading, and it is impor-
tant to remember that in silico metabolic networks only reveal
the metabolic potential of these organisms. The actualization
of this potential is restricted by numerous levels of regulation,
including lifecycle-specific gene expression, subcellular protein
localization, enzyme concentration and posttranslational regula-
tion, metabolite transport, and substrate, product, and cofactor
abundance. Global transcriptional and proteomic analyses have
helped narrow these questions by revealing which parts of the
networks are coexpressed but unfortunately cannot directly
describe the cellular metabolic status. Hence, integrating mech-
anisms of regulation with the actual readout of metabolic activity,
metabolite levels, and fluxes is crucial for a systematic under-
standing of parasite metabolism and rational identification of
drug targets. Of course, obligate intracellular parasites pose
a unique challenge to flux analysis because two interconnected
metabolic networks are at work: that from the host and that of theparasite. Therefore, defining the source of the labeled metabo-
lites is more difficult. Furthermore, nutrients that are solely ob-
tained from the host cell will be difficult to label for the study of
parasite metabolism, making flux analysis virtually impossible
for these nutrients.
Break Something and Measure What Happens:
Applications to Reverse Genetics
Combining metabolomics with reverse genetics (genetic or
chemical knockouts/knockdowns) is very appealing, particularly
for targets with potential enzymatic activity, as it allows for the
rapid characterization of hundreds of metabolic phenotypes
simultaneously. For this reason, it has been one of the areas in
the study of parasites in which metabolomics has taken a solid
foothold. In the Apicomplexa, due to their haploid genomes,
knockout parasite lines are particularly well suited for metabolo-
mic studies. The susceptibility of T. brucei to RNA interference
(Wang et al., 2000) enables a powerful combination of reverse
genetics and metabolomics among the kinetoplasts.
Van Weelden et al. used a combination of HPLC-UV/conduc-
tivity detection, 14C-radiolabeled glucose, and 13C-NMR to
measure glycolysis and TCA cycle intermediates, as well as
ATP/ADP/AMP/Pi levels, in a T. brucei wild-type strain and two
independent aconitase knockout strains to validate the dispens-
ability of the TCA cycle for energy generation in T. brucei procy-
clic forms (van Weelden et al., 2003). In a second metabolomic
study of T. brucei, Coustou et al. used 13C-NMR to compare
the utilization of D-[1-13C]-glucose (preferred) or L-[4-13C]-
proline (highly available in the insect host) as the primary carbon
source for wild-type procyclic forms. Combining this approach
with RNAi knockdownmutants, the authors were able to develop
a detailed metabolic model of proline utilization in the presence
and absence of glucose (Coustou et al., 2008).
Studies using 13C-NMR in Leishmania have taken ametabolo-
mics approach to investigate the critical role of fructose-1,6-bi-
sphosphatase in gluconeogenesis for L. major survival in macro-
phages by illustrating the parasite’s inability to utilize labeled
fatty acids as gluconeogenic substrates and demonstrating the
loss of virulence in fructose-1,6-bisphosphatase knockout para-
sites (Naderer et al., 2006). De Souza et al. used the effect of two
gene deletions (a glucose transporter and phosphomannose
isomerase) on the L. mexicanametabolome to validate improved
noise filtering using a new peak clustering algorithm, comparing
metabolite extracts from wild-type and knockout strains (De
Souza et al., 2006).
In an apicomplexan example, Olszweski et al. used LC-MS of
growth medium from cultures of synchronized malaria parasites
to link arginine depletion and ornithine enrichment to the parasite
arginase by demonstrating stable arginine and ornithine levels
in ex vivo cultures of arginase knockout P. berghei parasites
(Olszewski et al., 2009).
Currently, there are numerous genetically altered parasite lines
available (http://www.mr4.org, http://www.atcc.org, and http://
www.pberghei.eu), which could be used to assay metabolic
perturbations due to genetic lesion. Recent studies have gener-
ated type II fatty acid synthesis (FAS II) knockoutmutants inPlas-
modium spp. (Vaughan et al., 2009; Yu et al., 2008) and Toxo-
plasma gondii (Mazumdar et al., 2006) and demonstrate
genetically that FAS II is essential only during late-stage liver
development in Plasmodium but necessary for tachyzoiteCell Host & Microbe 7, February 18, 2010 ª2010 Elsevier Inc. 93
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ization of the metabolic phenotypes downstream of these muta-
tions under both lethal and nonlethal conditions using metabolo-
mic approaches for both parasites.
From Metabolites to Genes: Applications to Forward
Genetics
The application of quantitative trait locus analysis to quantitative
measurements of global metabolite levels (mQTL) has emerged
as a powerful tool for dissecting the genetic basis of metabolism
in plants (Keurentjes et al., 2006). Assaying 84 metabolites (50 of
known chemical structure) by GC-MS in shoots of 429 geno-
typed inbred A. thaliana lines, Lisec et al. were able to identify
157 metabolite-specific QTLs, mapping to enzymes in the
appropriate metabolic pathway for 67% of QTLs. The number
of contributing loci varied from just 1 for each of 42 metabolites
to 6 QTLs contributing to tyrosine metabolism. Furthermore, the
study revealed the presence of mQTL hot spots, loci that affect
the levels of many different metabolites (Lisec et al., 2008).
Several sets of genotyped F1 lines are available from crosses
in both P. falciparum (Hayton et al., 2008; Walliker et al., 1987;
Wellems et al., 1990) and T. gondii (Sibley and Boothroyd,
1992; Su et al., 2002). Using QTL analysis, these crosses have
been used successfully to map the genetic basis of a number
of phenotypes, including resistance to a variety of drugs (Ferdig
et al., 2004; Fidock et al., 2000; Mu et al., 2003; Nair et al., 2008;
Yuan et al., 2009), host cell binding (Hayton et al., 2008), and viru-
lence (Saeij et al., 2006; Taylor et al., 2006). Given a sufficient
difference in metabolic phenotypes of the parental strains, me-
tabolomic analyses of daughter lines from these crosses could
be used to map the genetic basis of a variety of phenotypes,
including starvation responses, compensatory mechanism in
response to manipulation of metabolic genes, and metabolic
effects of drug treatment, potentially identifying unintended,
secondary drug targets.
Controlling the Machinery: Metabolomics and Gene
Regulation
Understanding the interplay of an organism’s environment and
regulation of gene expression were among the first problems
of molecular genetics (Jacob and Monod, 1961). What started
out as a simple system of less than a dozen components control-
ling lactose utilization by E. coli has grown into the study of
systems biology, monitoring gene expression across an organ-
ism’s entire genome and measuring hundreds of metabolites
within the organism and the environment.
Correlating transcriptional responses to environmental stimuli
has yielded a deeper, systematic understanding of the biology of
a great variety of organisms, such as environmental adaptation
by extremophiles (Trauger et al., 2008), optimizing bacterial
biofuel production (Yang et al., 2009), understanding yeast
metabolic cycle changes in response to environmental distur-
bances (Gasch et al., 2000), and temperature stress in fruit
flies (Pedersen et al., 2008). But combining the study of gene
expression at either the transcript or protein level with metabolo-
mic approaches has been rare in the study of host-parasite
interaction.
In order to compare the response of mice either resistant or
susceptible to cerebral malaria, Rae et al. measured gene tran-
script levels of 21 metabolic and immune response genes ex-
pressed in the brain and determined brain metabolite levels94 Cell Host & Microbe 7, February 18, 2010 ª2010 Elsevier Inc.using 13C- and 31P-NMR but were unable to correlate changes
in gene expression and metabolite levels in mice susceptible to
cerebral malaria (Rae et al., 2004). This could possibly be due
to the fact that correlations of gene expression and metabolite
changes occur in amore localized fashion and are lost when inte-
grated over a whole organ as diverse as the brain.
Two P. falciparum studies have correlated changes in malaria
gene expression with metabolite measurements over the intraer-
ythrocytic developmental cycle using global transcription micro-
array and LC-MS/MS analysis. Olszewski et al. monitored the
levels of 119 metabolites in synchronized P. falciparum culture
at 8 hr intervals, sampling both the media and infected red blood
cells while simultaneously extracting total RNA for microarray
analysis. Several metabolites correlated strongly with transcript
levels of enzymes involved in their synthesis and/or catabolism,
including 5-methylthioinosine and a-ketoglutarate (Olszewski
et al., 2009).
Taking a broad systems approach, van Brummelen et al. char-
acterized the global effect of inhibiting the bifunctional enzyme
PfAdoMetDC/ODC on the Plasmodium falciparum intraerythro-
cytic developmental cycle by following global transcript, protein,
and metabolite abundance, using DNA microarrays, 2D PAGE-
MALDI-MS/MS, and LC-MS/MS, respectively (van Brummelen
et al., 2009). PfAdoMetDC/ODC inhibition resulted in growth
arrest and compensatory changes at the transcript and protein
level, including downregulation of several enzymes in the
polyamine synthesis pathway downstream of PfAdoMetDC/
ODC, while ornithine decarboxylase, which generates the
PfAdoMetDC/ODC substrate ornithine, increased along with
lysine decarboxylase, which produces the polyamine cadaverine
independently of PfAdoMetDC/ODC. As expected, metabolite
analysis revealed a significant drop in parasite polyamine levels,
specifically spermidine and putrescine, with a concomitant rise
in the upstream metabolite S-adenosylmethionine.
These studies mark the first steps toward parasite systems
biology and illustrate how parasite metabolite levels fluctuate
in response to changes in parasite gene expression at the tran-
scriptional and protein level and how metabolite concentrations
can feed back to regulate expression of metabolic genes.
It Takes Two to Tango: Metabolomics of Host-Parasite
Systems
By its very nature, parasite metabolism cannot be understood
without integrating it with that of the host. Metabolomic profiling
of host fluids and tissues and changes in response to infection
with protozoan parasites are critical for understanding parasite
pathogenesis and show promise for use in diagnostics.
Biomarkers of Infection
A major goal of the application of metabolomics to the study of
parasites is the identification of diagnostic biomarkers. Standard
diagnostic methods for parasitic infections rely heavily on
microscopy, which is time intensive and requires highly trained
personnel, as well as specialized equipment. Metabolomic iden-
tification of infection biomarkers is an important step toward the
development of rapid and cost-effective diagnostics (Holmes
et al., 2008). Identification of infection biomarkers has been
successful in a variety of experimental systems, including in
the plasma of lymphocytic choriomeningitis virus-infected mice
(Wikoff et al., 2009b), in the cerebral spinal fluid of simian immu-
nodeficiency virus-infected rhesus macaques (Wikoff et al.,
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et al., 2006).
Sample acquisition for diagnostic purposes can be intrusive
and requires sterile equipment not always available, making
the use of biomarkers from nonintrusive samples (saliva/urine)
particularly appealing. This approach has already been applied
successfully in the diagnosis of a number of nonparasite disease
states (reviewed in Nordstrom and Lewensohn, 2009), including
early diagnosis of various cancers, markers of renal failure, and
response to a variety of drugs. The development of metabolic
biomarkers of parasite infection for diagnostic purposes remains
in its infancy, but promising work has emerged during the past
few years.
Recently, several studies have used both NMR (Li et al., 2009;
Nishina et al., 2004; Saric et al., 2009; Wang et al., 2004) and UV
spectroscopy (Angulo et al., 2009) for metabolomic analysis of
host samples (plasma, urine, or stool) to identify biomarkers of
infection with a variety of parasitic helminths. These approaches
were able to differentiate infected from uninfected animals, often
early in the course of infection, using either abundance changes
in the metabolomic profile or metabolites unique to infected
animals. Similarly, metabolite analysis of histological samples
was able to demonstrate tissue-specific responses to infection.
A shared thread of these studies was significant changes in
metabolites produced by the intestinal flora following infection
with intestinal and extraintestinal helminths alike, indicating
that changes in the composition of the intestinal flora can
have significant effects on the metabolite profile of the host
(Wikoff et al., 2009a; Yap et al., 2008) andare a commonoutcome
of infection.
Markers of Protozoan Infection
Fewer metabolomic studies have attempted to develop
biomarkers of protozoan infections. Using 1H-NMR and working
in the P. berghei mouse model, Li et al. found drastic decreases
in plasma glucose levels and a concomitant rise of lactate and
pyruvate as the result of anaerobic glycolysis by the parasite,
as well as a drop in glycerophosphoryl choline, which acts as
a source of choline for the parasite. Analysis of urine from in-
fected mice again found evidence of changes in the intestinal
flora and, of note, excretion of pipecolic acid and two unknown
metabolites absent from the urine of uninfected mice, though
many of these changes only became apparent when parasitemia
exceeded 15% of circulating erythrocytes (Li et al., 2008).
Using 13C- or 31P-NMR and P. berghei, Rae et al. compared
brain glucose metabolism and bioenergetics in response to
infection with the ANKA strain, which causes cerebral malaria,
to infection with the K173 strain, which does not. In mice with
cerebral malaria, there was a notable reduction in brain meta-
bolic activity along with a shift in D-[1-13C]-Glucose utilization
from the TCA cycle to (1) anaerobic metabolism, (2) the gluta-
mate/glutamine cycle, and (3) the GABA shunt. The increased
utilization of the glutamate/glutamine cycle preceded increases
in lactate and alanine, suggesting that increased gluteminergic
metabolism is not the result of brain hypoxia but is due to other
metabolic disturbances. Mice infected with the K173 strain, on
the other hand, displayed evidence of increased (2-fold) cere-
bral metabolic rate with elevated glucose utilization and relatively
uniform incorporation into metabolites. Energy metabolism as
monitored by 31P-NMR revealed a significant increase ininorganic phosphate and phosphocreatine, consistent with
increased anaerobic metabolism and cerebral hypoxia in mice
with cerebral malaria (Rae et al., 2004).
A third study compared the effects of P. berghei ANKA infec-
tion in mice susceptible (CBA/J) or resistant (BALB/c) to cerebral
malaria via in vivo NMR and 1H/31P-NMR metabolite profiling of
blood and brain extracts. Cerebral malaria-susceptible mice
showed brain anomalies absent from resistant mice at similar
parasitemia levels, including an unexpected elevation of cerebral
blood flow. Measuring brain metabolite levels revealed a notable
drop in choline-derived compound levels, important for
membrane and myelin homeostasis (Penet et al., 2007). Further-
more, this study found increases in brain glutamine and alanine
levels in susceptible mice, consistent with increased blood
ammonia levels, as well as the decreased levels of brain
myo-inositol, which are thought to compensate for increased
intracellular osmolarity due to glutamine accumulation. These
changes are compatible with hepatic encephalopathy and
were supported by significantly increased blood bilirubin levels,
significant changes in liver enzyme function, and an overall
increase of hepatic tissue pathology in susceptible mice (Penet
et al., 2007).
Tracking the urine and plasma metabolome for 33 days by
1H-NMR allowed for the differentiation of mice infected by
African trypanosomes from uninfected animals, starting at
1 day postinfection, with differences becoming more pro-
nounced as the infection progressed (Wang et al., 2008). Notable
changes in urine were seen for several markers, including
3-carboxy-2-methyl-3-oxopropanamine as a unique marker of
infection. Analysis of plasmametabolite levels was able to corre-
late increases in lactate, oxaloacetate, and glucose, as well as
decreases in glutamine and lysine with infection. Starting on
day 7, there were also notable changes in plasma markers.
The identification of several unique urinary metabolites present
early in disease progression is promising, as treatment options
for African trypanosomiasis are considerably better while the
parasite remains confined to the bloodstream. Once the parasite
crosses the blood-brain barrier, prospects of survival dim
considerably. Identification of urine or plasma biomarkers of
central nervous system invasion by the parasite would mark
a major advance beyond the diagnostic standard of microscopic
inspection of cerebral spinal fluid.
So far, metabolomic biomarker studies of parasite infections
have performed well in differentiating infected from uninfected
animals and in highlighting the effect of infection on the intestinal
flora. However, these approaches remain far from being useful in
a diagnostic context, as many of these biomarkers appear to
simply be indicators of infection rather than being pathogen
specific (Koulman et al., 2009). Blinded studies using several
pathogens and the same host will be needed to validate the
use of metabolomics in producing correct differential diagnoses.
For instance, changes in the composition of the host’s intestinal
microflora can result in major changes of blood and urinemetab-
olites (Wikoff et al., 2009a; Yap et al., 2008) and appear to be
a common side effect in parasitic infections. The recurrence of
cometabolites (e.g., trimethylamine or hippurate) produced by
the intestinal flora as prominent biomarkers in these model
systems using controlled nutrition and isogenic hosts fore-
shadows the large potential for variability when the diversity ofCell Host & Microbe 7, February 18, 2010 ª2010 Elsevier Inc. 95
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is considerably higher.
One current application of metabolomics to medical parasi-
tology has been in the diagnosis and monitoring of large hydatid
cysts in the brains and peritoneal cavity that are caused by
cestodes in the genus Echinococcus. These cysts can be diag-
nosed and monitored by MRI and display characteristically
high end product metabolites of the parasite’s anaerobic glycol-
ysis, which decrease with successful treatment (Seckin et al.,
2008). Such metabolite-based diagnostics hold great promise
for the future and will ultimately enable rapid assessment of
patients in the field.
Future Directions
Global metabolite analysis is a powerful tool for understanding
the biology of protozoan parasites and host-parasite interac-
tions. In this review, we have presented a wide variety of applica-
tions for metabolomics to protozoan parasites, including work
toward integrating global metabolite levels with genomic, tran-
scriptional, and proteomic analysis in search of a systems-level
understanding of parasite metabolism and gene regulation.
Given the dire need for better antiparasitic drugs and diagnos-
tics, metabolomics is becoming a valuable tool in identifying
potential drug targets and defining markers of infection. In addi-
tion, characterizing the effect of novel drugs on host and parasite
metabolite levels promises to identify their mechanisms of
action. A number of fascinating questions in parasite biology
are likely to benefit tremendously throughmetabolomic analysis.
Of great interest is the dissection of potentially noncanonical
biochemical pathways and of parasite-specific metabolism.
One such example is deciphering the actual function of the
tricarboxylic acid (TCA) cycle of blood-stage malaria, as it is
known not to be a major source of energy or reducing power in
these parasites (Mogi and Kita, 2009; Seeber et al., 2008).
Probing the TCA cycle using metabolite flux with 13C-enriched
nutrients is likely to yield novel insights into how these parasites
utilize TCA cycle enzymes and their contribution to central
carbon metabolism.
Recent work by Blume et al. showed that TgGT1, the major
glucose transporter at the parasite plasma membrane of T. gon-
dii, is nonessential for parasite growth in vitro but results in
growth and motility defects that can be partially ameliorated by
increasing media glutamine levels (Blume et al., 2009). Metabo-
lomic characterization of this substrate switch could provide
insight into the robustness of T. gondiimetabolism and its ability
to adapt to changing nutritional environments.
Other promising applications include understanding how
parasite metabolic requirements vary upon differentiating from
one life stage to the next or following transmission to new host
species. For example, as Toxoplasma parasites differentiate
into slow-growing bradyzoites, they become increasingly resis-
tant to many drugs effective against the fast-growing tachyzoite
stage, yet the underlying metabolic changes responsible for this
resistance are still poorly understood. Similarly, when malaria
parasites differentiate into sexual-stage gametocytes, they
become increasingly resistant to many drugs that are effective
against the other blood stages. A further area of interest would
be the use of metabolomics to explore the host response to
parasite infection both in terms of how parasites siphon energy96 Cell Host & Microbe 7, February 18, 2010 ª2010 Elsevier Inc.and metabolites from the host and how the host can modify its
metabolism to combat the infection, as in the case of tryptophan
restriction in mice to control growth of Toxoplasma (Da¨ubener
et al., 2001). With the recent advances in methodologies for
measuring complex mixtures of cellular biomolecules, metabo-
lomic studies of parasites hold great promise for the improved
understanding and control of protozoan parasites.
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